Seoul, South Korea

Ick-Chan Kwon

USPTO Granted Patents = 12 


 

Average Co-Inventor Count = 5.3

ph-index = 5

Forward Citations = 164(Granted Patents)


Company Filing History:


Years Active: 2001-2016

where 'Filed Patents' based on already Granted Patents

12 patents (USPTO):

Title: Ick-Chan Kwon: Innovator in Anticancer Prodrugs

Introduction

Ick-Chan Kwon is a prominent inventor based in Seoul, South Korea. He has made significant contributions to the field of medicinal chemistry, particularly in the development of anticancer prodrugs. With a total of 12 patents to his name, Kwon's work focuses on enhancing the efficacy and safety of cancer treatments.

Latest Patents

One of Kwon's latest patents is an anticancer prodrug activated by radiation or ultraviolet treatment. This innovative prodrug consists of a peptide linked to an anticancer drug, such as doxorubicin, which is typically unstable in acidic or basic environments. The prodrug remains in a non-toxic inactive form when administered into the body. However, it effectively releases the active anticancer drug in the target area when exposed to caspase activated by radiation or UV treatment. This mechanism allows for selective anticancer effects on cancer cells, maximizing therapeutic benefits while minimizing the side effects commonly associated with chemotherapy.

Career Highlights

Kwon has worked with notable organizations, including the Korea Institute of Science and Technology and Daehwa Pharm Co., Ltd. His experience in these institutions has contributed to his expertise in drug development and innovation in cancer therapies.

Collaborations

Throughout his career, Kwon has collaborated with esteemed colleagues such as Kui-Won Choi and Kwang-Meyung Kim. These partnerships have fostered a collaborative environment that enhances research and development in the field of anticancer treatments.

Conclusion

Ick-Chan Kwon's innovative work in the development of anticancer prodrugs represents a significant advancement in cancer therapy. His contributions not only aim to improve treatment outcomes but also focus on reducing the adverse effects of chemotherapy.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…